Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Eur J Immunol. 2009 Nov;39(11):3239–3250. doi: 10.1002/eji.200839087

Figure 5. p38 MAPK inhibitor and NF-κB inhibitor reduced microbial activation of TL1A expression.

Figure 5

Monocytes were incubated with either p38 MAPK inhibitors (SB-203580 or SB-239063), NF-κB inhibitors (MG132, QNZ, or IKK-NBD), or negative control for NF-κB inhibitor (IKK-Control) in combination with E. coli. (A) TL1A mRNA was analyzed by real-time RT-PCR and expressed as relative expression. (B) Cells were stained for surface TL1A expression and analyzed by flow cytometry. (C) TL1A in supernatants was quantified by ELISA. Data shown are means ± SEM of at least three independent experiments. *, p<0.05. **, p<0.001.